CTSB and acute lymphoblastic leukemia: In the case of ALL, our group showed that ASNases possessing different sensitivity to the action of lysosomal proteases CTSB and AEP result in altered pharmacokinetic and immunological profiles in vivo (health mice model), but equal cytotoxicity against several ALL cell lines in vitro [2].